Viewing Study NCT01382160


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 1:26 AM
Study NCT ID: NCT01382160
Status: COMPLETED
Last Update Posted: 2025-12-22
First Post: 2010-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
Sponsor: University Hospital, Tours
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2013-07
Primary Completion Date Type: ACTUAL
Completion Date: 2013-07
Completion Date Type: ACTUAL
First Submit Date: 2010-12-02
First Submit QC Date: None
Study First Post Date: 2011-06-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-15
Last Update Post Date: 2025-12-22
Last Update Post Date Type: ESTIMATED